Rocket One Inc. (RKTO): Operating Cash Flow
-$9.80M
Year ended 2025-12-31
-$10.66M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$9.80M | n/m | 2026-03-27, From 2025-01-01 |
| 2024-12-31 | -$6.98M | n/m | 2026-03-27, From 2024-01-01 |
| 2023-12-31 | -$8.45M | n/m | 2025-03-28, From 2023-01-01 |
| 2022-12-31 | -$9.30M | n/m | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | -$12.09M | n/m | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | -$6.13M | n/m | 2022-03-30, From 2020-01-01 |
| 2019-12-31 | -$4.95M | n/m | 2021-03-16, From 2019-01-01 |
| 2018-12-31 | -$2.10M | n/a | 2020-03-02, From 2018-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Rocket One Inc. (RKTO) | 2025-12-31 | -$9.80M | n/m |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | -$4.66M | n/m |
| Oncolytics Biotech Inc (ONCY) | 2025-12-31 | -$20.11M | n/m |
| Acurx Pharmaceuticals, Inc. (ACXP) | 2025-12-31 | -$6.79M | n/m |
| Ensysce Biosciences, Inc. (ENSC) | 2025-12-31 | -$7.81M | n/m |
| Processa Pharmaceuticals, Inc. (PCSA) | 2025-12-31 | -$11.39M | n/m |
| Dermata Therapeutics, Inc. (DRMA) | 2025-12-31 | -$7.76M | n/m |
| Telomir Pharmaceuticals, Inc. (TELO) | 2025-12-31 | -$3.69M | n/m |
| Matinas BioPharma Holdings, Inc. (MTNB) | 2025-12-31 | -$7.01M | n/m |
Compare RKTO, SILO, ONCY, ACXP side by side · Screen every company in Pharmaceutical Preparations ↗